Validation study of the efficacy of frailty discriminant score (FDS) in patients with urological cancers
Not Applicable
- Conditions
- rological cancers (Prostate cancer: PC, bladder cancer: BC, upper tract urothelial carcinoma: UTUC, renal cell carcinoma: RCC) Controls (Ctrl) Subjects who participated in the general health survey in the IWAKI health promotion project between 2013 and 2018.
- Registration Number
- JPRN-UMIN000036497
- Lead Sponsor
- Hirosaki Univ. School of Med.
- Brief Summary
The frailty discriminant score (FDS) is a reliable and valid tool for assessing frailty and prognosis in patients with urological cancers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 559
Inclusion Criteria
Not provided
Exclusion Criteria
Key exclusion criteria: 1) patients with cancer except for PC, BC, UTUC, or RCC. 2) patients with severe general condition who could not evaluate the frailty using FDS. Controls (Ctrl)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method